R&D, Pharmacovigilance & Regulatory Affairs_tr

Ar-Ge, Farmakovijilans ve Ruhsatlandırma İşleri

Yeni ilaç çözümleri araştırma, geliştirme, test etme ve piyasaya sürme. Geliştirme süreci 8 ila 10 yıl sürer ve 4 fazdan oluşur.

  • Ar-Ge, Farmakovijilans ve Ruhsatlandırma İşleri

    Yeni ilaç çözümleri araştırma, geliştirme, test etme ve piyasaya sürme. Geliştirme süreci 8 ila 10 yıl sürer ve 4 fazdan oluşur.

Başlık Konum Tarih Sort descending Req ID
Sıfırla
Senior Manager, CMC Regulatory Affairs, Global Rare Diseases Europe, IT 8 May 2026 6592
Pharmaceutical Affairs Manager | All genders | Full-time Vienna, AT 5 May 2026 7255
Pharmazeut (all genders) im Praktikum für 2026 / 2027 Hamburg, DE 4 May 2026 351
Head of Biologic Drug Substance - Process & Analytical Development Parma, IT 30 Nis 2026 7233
Global Pharmacovigilance Medical Safety Writer - Temporary Parma, IT 28 Nis 2026 7237
INTERN - Patient Engagement
INTERN - Patient Engagement PARMA, IT 26 Nis 2026 5993
PARMA, IT 26 Nis 2026 5993
Translational and Precision Medicine Lead 1
Translational and Precision Medicine Lead 1 Europe - remote, GB 16 Nis 2026 7208
Europe - remote, GB 16 Nis 2026 7208
Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases Europe, IT 15 Nis 2026 6111
INTERN - Clinical Supply Management & Distribution Parma, IT 14 Nis 2026 7186
Master's thesis in computational modelling of aerosol deposition in respiratory system Parma, IT 11 Nis 2026 6598
Clinical Program Leader
Clinical Program Leader Cary, NC, US 11 Nis 2026 7017
Cary, NC, US 11 Nis 2026 7017
Senior Director, Clinical Biometrics & Analytics Parma, IT 11 Nis 2026 6387
Regulatory Affairs Specialist
Regulatory Affairs Specialist Barcelona, ES 11 Nis 2026 6966
Barcelona, ES 11 Nis 2026 6966